D. Galdermans

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Jacques De Grève, Erik Teugels, Caroline Geers et al. · Lung Cancer · 2012 · 277 citations · Full text

Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer

Abdelbari Baitar, Frank Van Fraeyenhove, A. Vandebroek et al. · Journal of Geriatric Oncology · 2012 · 133 citations · Full text

Geriatric Oncology, Aging, Screening Tools +9

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma

Jacques De Grève, Teresa Morán, Marie-Pascale Graas et al. · Lung Cancer · 2015 · 86 citations

Medicine, Lung Adenocarcinoma, Pathology +6

Are patients’ preferences for information and participation in medical decision-making being met? Interview study with lung cancer patients

Koen Pardon, Reginald Deschepper, Robert Vander Stichele et al. · Palliative Medicine · 2010 · 60 citations

Family Medicine, Behavioral Decision Making, Clinical Decision-making +19

Preferences of Patients with Advanced Lung Cancer Regarding the Involvement of Family and Others in Medical Decision-Making

Koen Pardon, Reginald Deschepper, Robert Vander Stichele et al. · Journal of Palliative Medicine · 2010 · 47 citations · Full text